EOM 1352: Fri 7 June 2024, 11:36

Current Edition

ramusmedical
Regional News

‘No small feat’: Albireo CEO talks biotech’s commercial transition amid Bylvay launch

Established in Sweden as a small spinout of AstraZeneca in 2008, Albireo always had big ambitions. After all, it was named after the striking “double star” in the Cyg...
Continue Reading →
Quotient